Clinical trial
Combination Chemotherapy Compared With Observation After Surgery in Treating…
NCT00053911 · UNICANCER, Other · Terminated
Key facts
| NCT number | NCT00053911 |
|---|---|
| Title | Combination Chemotherapy Compared With Observation After Surgery in Treating Women With Relapsed Nonmetastatic Breast Cancer |
| Official title | Randomized And Multicentric Phase III Study Evaluating The Benefit By Using A Chemotherapy With FEC 100 And Docetaxel In Non Metastatic Breast Cancer Which Has Relapsed After A Conservative Surgery |
| Lead sponsor | UNICANCER, Other |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug, Procedure |
| Interventions | anastrozole, cyclophosphamide, docetaxel, epirubicin hydrochloride, fluorouracil, goserelin acetate, tamoxifen citrate, adjuvant therapy |
| Start date | Nov 1, 2002 |
| Primary completion | Apr 1, 2004 |
| First posted | Feb 6, 2003 |
| Last update posted | Dec 16, 2014 |
| Countries | France |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: